The decline of BCG immunity after neonatal vaccination: what about revaccination at one year?

H Aydinlioglu1, S Caglayan, S Kansoy

  • 1SSK Tepecik Teaching Hospital, Izmir, Turkey.

Insights

BCG vaccine immunity wanes over time in newborns, dropping from 87% to 61% reactivity by 12 months. Revaccination ensures 100% reactivity, and scar presence indicates immunity.

Area of Science:

  • Immunology
  • Pediatrics
  • Public Health

Background:

  • The Bacillus Calmette-Guérin (BCG) vaccine is crucial for preventing tuberculosis (TB) in newborns.
  • Understanding the duration and indicators of BCG vaccine-induced immunity is vital for public health strategies.

Purpose of the Study:

  • To assess the persistence of tuberculin reactivity after BCG vaccination in healthy newborns.
  • To evaluate the effectiveness of revaccination in nonreactive infants.
  • To explore the correlation between BCG vaccination scar formation and tuberculin reactivity.

Main Methods:

  • A cohort of 219 healthy newborns received the BCG vaccine.
  • Tuberculin reactivity was measured at 3, 6, and 12 months post-vaccination.
  • Scar assessment was performed on the left deltoid region.

Main Results:

  • Tuberculin reactivity decreased from 87% at 3 months to 61% at 12 months.
  • Revaccination of infants who were not reactive to tuberculin resulted in a 100% reactivity rate.
  • A strong correlation was observed between tuberculin reactivity and the presence of a BCG vaccination scar.

Conclusions:

  • BCG vaccine-induced immunity, as indicated by tuberculin reactivity, wanes significantly within the first year of life.
  • Revaccination is effective in restoring tuberculin reactivity.
  • BCG scar formation serves as a reliable indicator of a child's immunity to tuberculosis, potentially simplifying post-vaccination monitoring.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Immunological Memory01:23

Immunological Memory

Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.